BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

839 related articles for article (PubMed ID: 8538617)

  • 1. PPAR: a mediator of peroxisome proliferator action.
    Green S
    Mutat Res; 1995 Dec; 333(1-2):101-9. PubMed ID: 8538617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptors: finding the orphan a home.
    Green S; Wahli W
    Mol Cell Endocrinol; 1994 Apr; 100(1-2):149-53. PubMed ID: 8056148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The peroxisome proliferator-activated receptor:retinoid X receptor heterodimer is activated by fatty acids and fibrate hypolipidaemic drugs.
    Issemann I; Prince RA; Tugwood JD; Green S
    J Mol Endocrinol; 1993 Aug; 11(1):37-47. PubMed ID: 8240670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Proliferation of peroxisomes and the hepatocarcinogenic process].
    Palut D
    Rocz Panstw Zakl Hig; 1997; 48(1):1-11. PubMed ID: 9273657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferators and peroxisome proliferator activated receptors (PPARs) as regulators of lipid metabolism.
    Latruffe N; Vamecq J
    Biochimie; 1997; 79(2-3):81-94. PubMed ID: 9209701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisome proliferators: a model for receptor mediated carcinogenesis.
    Green S
    Cancer Surv; 1992; 14():221-32. PubMed ID: 1330305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation.
    Schoonjans K; Staels B; Auwerx J
    Biochim Biophys Acta; 1996 Jul; 1302(2):93-109. PubMed ID: 8695669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conjugated linoleic acid activates peroxisome proliferator-activated receptor alpha and beta subtypes but does not induce hepatic peroxisome proliferation in Sprague-Dawley rats.
    Moya-Camarena SY; Van den Heuvel JP; Belury MA
    Biochim Biophys Acta; 1999 Jan; 1436(3):331-42. PubMed ID: 9989264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression.
    Schoonjans K; Staels B; Auwerx J
    J Lipid Res; 1996 May; 37(5):907-25. PubMed ID: 8725145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transactivation by PPAR/RXR heterodimers in yeast is potentiated by exogenous fatty acid via a pathway requiring intact peroxisomes.
    Marcus SL; Miyata KS; Rachubinski RA; Capone JP
    Gene Expr; 1995; 4(4-5):227-39. PubMed ID: 7787415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptor alpha required for gene induction by dehydroepiandrosterone-3 beta-sulfate.
    Peters JM; Zhou YC; Ram PA; Lee SS; Gonzalez FJ; Waxman DJ
    Mol Pharmacol; 1996 Jul; 50(1):67-74. PubMed ID: 8700121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The molecular mechanism of peroxisome proliferator action: a model for species differences and mechanistic risk assessment.
    Green S; Tugwood JD; Issemann I
    Toxicol Lett; 1992 Dec; 64-65 Spec No():131-9. PubMed ID: 1335174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrogen peroxide generation in peroxisome proliferator-induced oncogenesis.
    Yeldandi AV; Rao MS; Reddy JK
    Mutat Res; 2000 Mar; 448(2):159-77. PubMed ID: 10725470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of the peroxisomal beta-oxidation-dependent pathway by peroxisome proliferator-activated receptor alpha and kinases.
    Latruffe N; Cherkaoui Malki M; Nicolas-Frances V; Clemencet MC; Jannin B; Berlot JP
    Biochem Pharmacol; 2000 Oct; 60(8):1027-32. PubMed ID: 11007938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptors, coactivators, and downstream targets.
    Qi C; Zhu Y; Reddy JK
    Cell Biochem Biophys; 2000; 32 Spring():187-204. PubMed ID: 11330046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is peroxisome proliferation an obligatory precursor step in the carcinogenicity of di(2-ethylhexyl)phthalate (DEHP)?
    Melnick RL
    Environ Health Perspect; 2001 May; 109(5):437-42. PubMed ID: 11401753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting peroxisome proliferator-activated receptors (PPARs) in kidney and urologic disease.
    Guan Y
    Minerva Urol Nefrol; 2002 Jun; 54(2):65-79. PubMed ID: 12185990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a peroxisome proliferator-responsive element upstream of the human peroxisomal fatty acyl coenzyme A oxidase gene.
    Varanasi U; Chu R; Huang Q; Castellon R; Yeldandi AV; Reddy JK
    J Biol Chem; 1996 Jan; 271(4):2147-55. PubMed ID: 8567672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of peroxisome proliferator-activated receptor-alpha mRNA in rat liver.
    Sterchele PF; Sun H; Peterson RE; Vanden Heuvel JP
    Arch Biochem Biophys; 1996 Feb; 326(2):281-9. PubMed ID: 8611035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of dose-response relationships for induction of lipid metabolizing and growth regulatory genes by peroxisome proliferators in rat liver.
    Belury MA; Moya-Camarena SY; Sun H; Snyder E; Davis JW; Cunningham ML; Vanden Heuvel JP
    Toxicol Appl Pharmacol; 1998 Aug; 151(2):254-61. PubMed ID: 9707502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.